Boule Diagnostics Past Earnings Performance
Past criteria checks 0/6
Boule Diagnostics's earnings have been declining at an average annual rate of -26.3%, while the Medical Equipment industry saw earnings growing at 9.1% annually. Revenues have been growing at an average rate of 4.1% per year. Boule Diagnostics's return on equity is 3.4%, and it has net margins of 2.9%.
Key information
-26.3%
Earnings growth rate
-33.5%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 4.1% |
| Return on equity | 3.4% |
| Net Margin | 2.9% |
| Next Earnings Update | 24 Jul 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Boule Diagnostics makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 23 | 559 | 16 | 146 | 53 |
| 31 Dec 22 | 548 | 13 | 144 | 52 |
| 30 Sep 22 | 539 | 27 | 138 | 50 |
| 30 Jun 22 | 525 | 32 | 131 | 48 |
| 31 Mar 22 | 495 | 28 | 126 | 45 |
| 31 Dec 21 | 463 | 23 | 120 | 43 |
| 30 Sep 21 | 416 | -27 | 115 | 42 |
| 30 Jun 21 | 403 | -13 | 113 | 42 |
| 31 Mar 21 | 383 | -55 | 107 | 44 |
| 31 Dec 20 | 400 | -48 | 111 | 43 |
| 30 Sep 20 | 437 | -8 | 116 | 41 |
| 30 Jun 20 | 470 | -8 | 119 | 37 |
| 31 Mar 20 | 499 | 35 | 130 | 32 |
| 31 Dec 19 | 499 | 38 | 128 | 30 |
| 30 Sep 19 | 476 | 32 | 126 | 31 |
| 30 Jun 19 | 456 | 21 | 124 | 33 |
| 31 Mar 19 | 444 | 36 | 115 | 33 |
| 31 Dec 18 | 424 | 41 | 110 | 29 |
| 30 Sep 18 | 425 | 48 | 111 | 24 |
| 30 Jun 18 | 424 | 60 | 112 | 25 |
| 31 Mar 18 | 421 | 43 | 111 | 27 |
| 31 Dec 17 | 428 | 37 | 116 | 32 |
| 30 Sep 17 | 422 | 31 | 114 | 38 |
| 30 Jun 17 | 421 | 28 | 110 | 38 |
| 31 Mar 17 | 419 | 38 | 109 | 38 |
| 31 Dec 16 | 397 | 36 | 105 | 37 |
| 30 Sep 16 | 383 | 36 | 97 | 40 |
| 30 Jun 16 | 364 | 22 | 96 | 42 |
| 31 Mar 16 | 341 | 15 | 93 | 42 |
| 31 Dec 15 | 331 | 15 | 89 | 40 |
| 30 Sep 15 | 333 | 29 | 95 | 31 |
| 30 Jun 15 | 318 | 33 | 91 | 26 |
| 31 Mar 15 | 309 | 33 | 89 | 23 |
| 31 Dec 14 | 307 | 30 | 88 | 24 |
| 30 Sep 14 | 289 | 14 | 83 | 24 |
| 30 Jun 14 | 285 | -68 | 83 | 25 |
| 31 Mar 14 | 287 | -64 | 84 | 24 |
| 31 Dec 13 | 277 | -70 | 84 | 24 |
| 30 Sep 13 | 281 | -65 | 85 | 25 |
| 30 Jun 13 | 275 | 8 | 86 | 24 |
| 31 Mar 13 | 274 | 7 | 82 | 24 |
| 31 Dec 12 | 275 | 11 | 80 | 22 |
| 30 Sep 12 | 267 | 10 | 76 | 24 |
| 30 Jun 12 | 261 | 12 | 73 | 24 |
Quality Earnings: BDAB.F has a high level of non-cash earnings.
Growing Profit Margin: BDAB.F's current net profit margins (2.9%) are lower than last year (5.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BDAB.F's earnings have declined by 26.3% per year over the past 5 years.
Accelerating Growth: BDAB.F's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: BDAB.F had negative earnings growth (-41.9%) over the past year, making it difficult to compare to the Medical Equipment industry average (3.7%).
Return on Equity
High ROE: BDAB.F's Return on Equity (3.4%) is considered low.